Gary Smith

Gary Smith is a seasoned professional in strategic pricing and contracting, currently serving as Senior Director at Alnylam Pharmaceuticals since November 2024. Prior to this role, Gary held significant positions at Eisai US, where responsibilities included leading the US Pricing and Contracting team as Senior Director, and at Celgene as Director of Market Access Contracting Strategy. Career achievements also include positions at Novartis and Express Scripts, where Gary managed financial modeling, contracting processes, and led teams providing analytical support. Gary holds an MBA in Finance from Rutgers University–Newark and a BBA in Finance from James Madison University.